FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 305:789-794 October 1, 1981 Number 14 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

In approximately 10 per cent of patients given digoxin, substantial conversion of the drug to cardioinactive, reduced metabolites (digoxin reduction products, or DRPs) occurs. The site and clinical importance of this conversion is unknown. In four normal volunteers taking digoxin daily for four weeks, urinary excretion of DRPs was greatest after a poorly absorbed tablet was ingested, and least after intravenous administration, Stool cultures from subjects known to make DRPs in vivo ("excretors") converted digoxin to DRPs; cultures from nonexcretors did not. Three excretors were given tablets for 22 to 29 days. A five-day course of erythromycin or tetracycline, administered after a base-line period of 10 to 17 days, markedly reduced or eliminated DRP excretion in urine and stool. Serum digoxin concentrations rose as much as twofold after antibiotics were given. We conclude that in some persons digoxin is inactivated by gastrointestinal bacteria. Changes in the enteric flora may markedly alter the state of digitalization.

This article has been cited by other articles:

• Cadle, R. M, Mansouri, M. D, Darouiche, R. O (2006). Vancomycin-Induced Elevation of Liver Enzyme Levels. The Annals of Pharmacotherapy 40: 1186-1189 [Abstract] [Full Text]  
• Zapater, P., Reus, S., Tello, A., Torrus, D., Perez-Mateo, M., Horga, J. F. (2002). A prospective study of the clarithromycin-digoxin interaction in elderly patients. J Antimicrob Chemother 50: 601-606 [Abstract] [Full Text]  
• Mishra, A., Friedman, H. S., Sinha, A. K. (1999). The Effects of Erythromycin on the Electrocardiogram. Chest 115: 983-986 [Abstract] [Full Text]  
• Valdes, R. Jr., Jortani, S. A., Gheorghiade, M. (1998). Standards of laboratory practice: cardiac drug monitoring. Clin. Chem. 44: 1096-1109 [Abstract] [Full Text]  
• Kowey, P. R. (1998). Pharmacological Effects of Antiarrhythmic Drugs: Review and Update. Arch Intern Med 158: 325-332 [Abstract] [Full Text]  
• Fouda, H. G., Avery, M. J., Dalvie, D., Falkner, F. C., Melvin, L. S., Ronfeld, R. A. (1997). Disposition and Metabolism of Tenidap in the Rat. Drug Metab. Dispos. 25: 140-148 [Abstract] [Full Text]  
• Midoneck, S. R., Etingin, O. R. (1995). Clarithromycin-Related Toxic Effects of Digoxin. NEJM 333: 1505-1505 [Full Text]  
• Zitelli, B. J., Howrie, D. L., Altman, H., Maroon, T. J. (1987). Erythromycin-induced Drug Interactions: An Illustrative Case and Review of the Literature. CLIN PEDIATR 26: 117-119 [Abstract]